Cited by 2Cardiac Valve Diseases and TreatmentsArtificial Intelligence in HealthcareECG Monitoring and Analysis

Validation and longitudinal trajectory analysis of an AI-based ECG model for aortic stenosis: from community screening to pre-TAVR risk stratification

Open access
Segar, Matthew W, Lambeth, Kaleb D, Postalian, Alexander, Coulter, Stephanie, Gilge, Jasen, Razvi, Naveed, Saeed, Mohammad, Paisley, Robert D +2 more·2026·European Heart Journal - Digital Health

Abstract

Aims: Early aortic stenosis (AS) detection remains challenging, with many patients presenting late when left ventricular dysfunction may be irreversible. We evaluated whether longitudinal AI-enhanced ECG patterns can predict outcomes years before intervention and assessed the community screening potential of the AK-AVS model. Methods and results: We conducted two complementary analyses: (1) community validation of the AK-AVS model in 3632 cardiovascular disease-free ARIC participants, and (2) longitudinal trajectory analysis of 7860 ECGs from 2040 TAVR recipients collected up to 10 years pre-procedure. Unsupervised clustering identified distinct AK-AVS trajectories, with mortality associations assessed using Cox regression and net reclassification improvement. In community screening (n = 16 moderate/severe AS), AK-AVS achieved an AUROC of 0.79, sensitivity 75%, and specificity 75% for moderate/severe AS. At hypothetical screening prevalences of 1–5%, positive predictive values improved to 3.1–14.3%. False-positive predictions identified individuals at 4-fold increased risk for future AS hospitalisation (HR 4.05, P < 0.001) and 52% increased risk for heart failure (HR 1.52, P = 0.02). In the TAVR cohort, trajectory analysis revealed three distinct patterns: Stable Low (19.3%), Accelerated Progression (23.6%), and Persistently High (57.1%). Elevated trajectory groups were older (78.4 and 77.8 vs. 72.6 years, P < 0.001) with higher pacemaker rates (16.4% and 17.3% vs. 10.7%, P = 0.008), despite similar hemodynamic severity. Both elevated patterns independently predicted mortality (Accelerated: HR 1.40, P = 0.03; Persistently High: HR 1.48, P = 0.005) and significantly improved risk reclassification beyond traditional risk scores (NRI 0.069–0.074). Conclusion: Longitudinal AI-ECG trajectory patterns detect disease progression up to 4.5 years before TAVR and enhance mortality prediction beyond traditional risk scores. Community validation shows potential screening utility with ‘false-positives’ identifying future risk.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ehjdh/ztag018

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Valvular and composite SHD AI-ECG models are promising for referral enrichment.

    “Valvular and composite SHD models are promising for referral enrichment”

    From AI-ECG for Echocardiography Triage in Structural Heart Disease: Evidence, Implementation, and Future Directions (2026) · cites this paper as [23]

    The Discussion (page not provided) proposes using an AI-ECG model for aortic stenosis to identify patients for confirmatory echocardiography, supporting the referral-enrichment idea for one valvular condition. It does not evaluate composite structural heart disease (SHD) models or establish the claim for valvular models generally. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Valvular AI-ECG has moved beyond proof of concept and shows meaningful referral enrichment, but prospective pathway validation remains limited.

    “From a deployment perspective, however, the practical conclusion is narrower: valvular AI-ECG has moved beyond proof of concept and shows meaningful referral enrichment, but prospective pathway validation remains limited.19,23”

    From AI-ECG for Echocardiography Triage in Structural Heart Disease: Evidence, Implementation, and Future Directions (2026) · cites this paper as [23]

    The Discussion (page unavailable) reports community validation of the aortic-stenosis AI-ECG model and projects that screening higher-risk patients would improve positive predictive value, with positive screens prompting echocardiography. It does not demonstrate referral enrichment in an implemented pathway; that is a proposed application. The Discussion also calls for prospective validation and randomized trials, supporting the qualification that pathway validation remains limited. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • In aortic stenosis, patients with positive AI-ECG results but no moderate-to-severe AS at baseline had a higher long-term risk of subsequently developing moderate-to-severe AS, and recent community validation showed a fourfold higher risk of future AS hospitalization among false-positive screens.

    “Analogous findings have been reported in aortic stenosis: patients with positive AI-ECG results but no moderate-to-severe AS at baseline had a higher long-term risk of subsequently developing moderate-to-severe AS, and recent community validation likewise showed a fourfold higher risk of future AS hospitalization among false-positive screens.19,23”
  • Emerging evidence supports longitudinal risk tracking in aortic stenosis and surveillance for treatment-related left ventricular dysfunction in cardio-oncology.

    “with emerging evidence supporting longitudinal risk tracking in aortic stenosis23 and surveillance for treatment-related left ventricular dysfunction in cardio-oncology.18”
  • Longitudinal AI-ECG trajectories in aortic stenosis can identify accelerated disease progression years before valve intervention.

    “Recent studies have shown that longitudinal AI-ECG trajectories in aortic stenosis can identify accelerated disease progression years before valve intervention,23”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [6]Martinez-Selles M, Marina-Breysse M. Current and future use of artificial intelligence in electrocardiography. J Cardiovasc Dev Dis 2023; 10: 175. 37103054 PMC10145690

Cited by

Sorted by citations

Authors
Segar, M. W., Lambeth, K. D., Postalian, A., Coulter, S., Gilge, J., Razvi, N., Saeed, M., Paisley, R. D., Pandey, A., & Razavi, M.
Affiliations
  • Department of Cardiology, Texas Heart Institute , 6770 Bertner Ave, Houston, TX 77030, USA
  • Department of Cardiac Electrophysiology , Ascension St. Vincent, Indianapolis, IN, USA
  • Ipswich Hospital (AU)
  • The University of Texas Southwestern Medical Center (US)
  • Baylor College of Medicine (US)
Corresponding author
Segar, Matthew W
Venue
European Heart Journal - Digital Health
Published
2026-01-27
Volume
7
Issue
2
Pages
ztag018-ztag018
ISSN
2634-3916 (ISSN-L)
OpenAlex
W7127344322
Cited by
2
References
36
Citations by year
2026: 2
FWCI
9.99
Type
journal article
Language
en
Open access
Locations
  • European Heart Journal - Digital Health (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • Digital Commons-TMC (Texas Medical Center) (submittedVersion)
Funders
  • Eli Lilly and Company
  • Pfizer
  • Gilead Sciences
  • Cytokinetics
  • Novo Nordisk
  • Idorsia Pharmaceuticals
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › ECG Monitoring and Analysis
Keywords
aortic stenosis, community-based screening, disease progression trajectories, mortality prediction, heart failure risk, pacemaker rate, ARIC cohort, unsupervised clustering, risk reclassification, false-positive screening results, left ventricular dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review